{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05044468",
            "orgStudyIdInfo": {
                "id": "2019-0237"
            },
            "secondaryIdInfos": [
                {
                    "id": "NCI-2021-08954",
                    "type": "REGISTRY",
                    "domain": "CTRP (Clinical Trial Reporting Program)"
                },
                {
                    "id": "2019-0237",
                    "type": "OTHER",
                    "domain": "M D Anderson Cancer Center"
                }
            ],
            "organization": {
                "fullName": "M.D. Anderson Cancer Center",
                "class": "OTHER"
            },
            "briefTitle": "EXPAREL or Lidocane as Local Anesthetic in Patients Undergoing Pleuroscopy With Pleural Biopsy and Indwelling Pleural Catheter Placement",
            "officialTitle": "A Randomized Blinded Controlled Trial of EXPAREL vs 1% Lidocane as Local Anesthetic in Patients Undergoing Pleuroscopy With Pleural Biopsy and Indwelling Pleural Catheter Placement",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "exparel-or-lidocane-as-local-anesthetic-in-patients-undergoing-pleuroscopy-with-pleural-biopsy-and-indwelling-pleural-catheter-placement"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-04",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-03-23",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-01-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-01-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-09-02",
            "studyFirstSubmitQcDate": "2021-09-13",
            "studyFirstPostDateStruct": {
                "date": "2021-09-14",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-04-23",
            "lastUpdatePostDateStruct": {
                "date": "2024-04-25",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "M.D. Anderson Cancer Center",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This phase II trial investigates the effect of EXPAREL compared to lidocane as a local anesthetic in patients who are undergoing pleuroscopy with pleural biopsy and indwelling pleural catheter placement. This trial aims to see whether EXPAREL or lidocane is able to make patients more comfortable.",
            "detailedDescription": "PRIMARY OBJECTIVE:\n\nI. To compare Global chest pain score (measured on the Visual Analog Scale \\[VAS\\] scale) post-procedure and post procedural chest pain (measured on the numerical rating scale), at the time of discharge from recovery between liposomal bupivacaine (EXPAREL) and 1 percent lidocaine.\n\nSECONDARY OBJECTIVES:\n\nI. To compare post procedural chest pain (measured on the numerical rating scale) at the time of discharge from recovery, 24 hours and 48 hours post procedure between EXPAREL and 1 percent lidocaine.\n\nII. To assess the change in global chest pain score (measured on the VAS scale) from baseline to the time of discharge from recovery, and post procedural chest pain (measured on the numerical rating scale) from baseline over time between EXPAREL and 1 percent lidocaine.\n\nIII. To compare the number of narcotics within 24 hours, and from 24 to 48 hours post procedure between EXPAREL and 1 percent lidocaine.\n\nOUTLINE: Patients are randomized to 1 of 2 groups.\n\nGROUP A: Patients receive liposomal bupivacaine via injection into the intercostal nerve block.\n\nGROUP B: Patients receive lidocaine via injection into the pleuroscopy port incision sites and indwelling pleural catheter site."
        },
        "conditionsModule": {
            "conditions": [
                "Malignant Pleural Neoplasm"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "SUPPORTIVE_CARE",
                "maskingInfo": {
                    "masking": "SINGLE",
                    "whoMasked": [
                        "PARTICIPANT"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 80,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Group A (liposomal bupivacaine)",
                    "type": "EXPERIMENTAL",
                    "description": "Patients receive liposomal bupivacaine via injection into the intercostal nerve block.",
                    "interventionNames": [
                        "Drug: Liposomal Bupivacaine",
                        "Other: Questionnaire Administration"
                    ]
                },
                {
                    "label": "Group B (lidocaine)",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Patients receive lidocaine via injection into the pleuroscopy port incision sites and indwelling pleural catheter site.",
                    "interventionNames": [
                        "Drug: Lidocaine",
                        "Other: Questionnaire Administration"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Lidocaine",
                    "description": "Given via injection",
                    "armGroupLabels": [
                        "Group B (lidocaine)"
                    ],
                    "otherNames": [
                        ".omega.-Diethylamino-2,6-dimethylacetanilide",
                        "2-(Diethylamino)-2'',6''-acetoxylidide",
                        "Cuivasil",
                        "Duncaine",
                        "Leostesin",
                        "Lidothesin",
                        "Lignocaine",
                        "Rucaina"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Liposomal Bupivacaine",
                    "description": "Given via injection",
                    "armGroupLabels": [
                        "Group A (liposomal bupivacaine)"
                    ],
                    "otherNames": [
                        "Bupivacaine Liposome Injectable Suspension",
                        "Exparel"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Questionnaire Administration",
                    "description": "Ancillary studies",
                    "armGroupLabels": [
                        "Group A (liposomal bupivacaine)",
                        "Group B (lidocaine)"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Global chest pain score",
                    "description": "Will be evaluated by the Global chest pain score at the time of discharge from recovery area using a Visual Analog Scale 0-100 and represents the pain experienced by the patient.",
                    "timeFrame": "Through study completion, an average of 1 year"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion criteria:\n\n1. Referral to pulmonary services for pleuroscopy with biopsies and IPC placement/chest tube placement\n2. Age \\> 18\n\nExclusion criteria:\n\n1. Inability to provide informed consent\n2. Study subject has any disease or condition that interferes with safe completion of the study including:\n\n   a. Allergic reaction to EXPAREL\n3. Need for pleurodesis\n4. Allergies to lidocaine or other local anesthetics.\n5. Pregnancy\n6. Advanced liver disease where the clinician deems the procedure unsafe",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Horiana Grosu, MD",
                    "role": "CONTACT",
                    "phone": "713-792-6238",
                    "email": "hbgrosu@mdanderson.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Horiana Grosu, MD",
                    "affiliation": "M.D. Anderson Cancer Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "M D Anderson Cancer Center",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Horiana Grosu",
                            "role": "CONTACT",
                            "phone": "713-792-6238",
                            "email": "hbgrosu@mdanderson.org"
                        },
                        {
                            "name": "Horiana Grosu",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "MD Anderson Cancer Center",
                    "url": "http://www.mdanderson.org"
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000010997",
                    "term": "Pleural Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000012142",
                    "term": "Respiratory Tract Neoplasms"
                },
                {
                    "id": "D000013899",
                    "term": "Thoracic Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000010995",
                    "term": "Pleural Diseases"
                },
                {
                    "id": "D000012140",
                    "term": "Respiratory Tract Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M13887",
                    "name": "Pleural Neoplasms",
                    "asFound": "Pleural Neoplasms",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14979",
                    "name": "Respiratory Tract Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M16658",
                    "name": "Thoracic Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M13885",
                    "name": "Pleural Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14977",
                    "name": "Respiratory Tract Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008012",
                    "term": "Lidocaine"
                },
                {
                    "id": "D000002045",
                    "term": "Bupivacaine"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000779",
                    "term": "Anesthetics, Local"
                },
                {
                    "id": "D000000777",
                    "term": "Anesthetics"
                },
                {
                    "id": "D000002492",
                    "term": "Central Nervous System Depressants"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000018689",
                    "term": "Sensory System Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000000889",
                    "term": "Anti-Arrhythmia Agents"
                },
                {
                    "id": "D000061567",
                    "term": "Voltage-Gated Sodium Channel Blockers"
                },
                {
                    "id": "D000026941",
                    "term": "Sodium Channel Blockers"
                },
                {
                    "id": "D000049990",
                    "term": "Membrane Transport Modulators"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M4107",
                    "name": "Anesthetics",
                    "relevance": "LOW"
                },
                {
                    "id": "M11014",
                    "name": "Lidocaine",
                    "asFound": "Stealth Liposomal Doxorubicin",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5315",
                    "name": "Bupivacaine",
                    "asFound": "Type",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4109",
                    "name": "Anesthetics, Local",
                    "relevance": "LOW"
                },
                {
                    "id": "M4213",
                    "name": "Anti-Arrhythmia Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M23177",
                    "name": "Sodium Channel Blockers",
                    "relevance": "LOW"
                },
                {
                    "id": "M30025",
                    "name": "Diuretics, Potassium Sparing",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "AnArAg",
                    "name": "Anti-Arrhythmia Agents"
                },
                {
                    "abbrev": "ChanBlk",
                    "name": "Channel Blockers"
                }
            ]
        }
    },
    "hasResults": false
}